Quarterly report pursuant to Section 13 or 15(d)

Restatements and Reclassifications - Schedule of Balance Sheet Table (Details)

v3.23.1
Restatements and Reclassifications - Schedule of Balance Sheet Table (Details) - USD ($)
$ in Thousands
Jul. 02, 2022
Apr. 02, 2022
Jan. 01, 2022
Jul. 03, 2021
Apr. 03, 2021
Jan. 02, 2021
Note receivable, net     $ 0      
Total assets $ 25,706   15,165      
Total liabilities     23,841      
Accumulated deficit     (53,804)      
Total stockholders' equity (deficit)     (8,676) $ 3,598 $ 8,490 $ 2,366
Total liabilities and stockholders' equity (deficit)     15,165      
Previously Reported            
Note receivable, net 11,277          
Total assets 27,519          
Total liabilities 24,301          
Accumulated deficit (41,914)          
Total stockholders' equity (deficit) 3,218          
Total liabilities and stockholders' equity (deficit) 27,519          
Effect of Restatement            
Note receivable, net (1,813)          
Total assets (1,813)          
Total liabilities 0          
Accumulated deficit (1,813)          
Total stockholders' equity (deficit) (1,813)          
Total liabilities and stockholders' equity (deficit) (1,813)          
As Restated            
Note receivable, net 9,464          
Total assets 25,706          
Total liabilities 24,301          
Accumulated deficit (43,727)          
Total stockholders' equity (deficit) 1,405 $ (7,510) $ (8,676)      
Total liabilities and stockholders' equity (deficit) $ 25,706